| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.003 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.004 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.006 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.006 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.008 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.008 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.14 | 0.008 |